Home » Topics » Disease categories and therapies » Immune

Immune
RSS

NIAID-sponsored scientists on the way to developing a broad-spectrum staph vaccine

June 1, 1999

Abgenix uses XenoMouse technology to generate new antibody for immunologic diseases

May 31, 1999

RotaShield vaccine receives marketing authorization in Europe

May 28, 1999

Use of ET antagonists for transplant rejection described by Knoll

May 27, 1999

SangStat presents new PKC modulator that inhibits transplant rejection in mice

May 27, 1999

Novel immunomodulatory peptide from SangStat prevents chronic transplant rejection

May 27, 1999

Immunosuppressive and antifungal sphingosine derivatives from Takara Shuzo

May 26, 1999

Abgenix MAb shows promise in GVHD following stem cell transplantation and heads for pivotal trials

May 25, 1999

Addition of BTI-322 to tacrolimus immunosuppression decreases incidence of transplant rejection

May 25, 1999

Cholera vaccine CVD103HgR-pDA60 is an excellent candidate for human studies

May 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...